ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,269Medicare Part D Prescriptions Filled, Including Refills

Rank: 83 out of 324

$644K Total Retail Price of All Prescriptions

Rank: 58 out of 324

656 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
7% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 656 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 656 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 9,476 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
SIMVASTATIN 487 455 1 1
AMLODIPINE BESYLATE 421 375 2 4
LISINOPRIL 399 384 3 3
LEVOTHYROXINE SODIUM 313 288 4 2
ATORVASTATIN CALCIUM 290 273 5 12
HYDROCODONE-ACETAMINOPHEN 238 207 S3 6 5
LOSARTAN POTASSIUM 224 206 7 15
CRESTOR 223 206 8 28
WARFARIN SODIUM 194 184 9 10
SYNTHROID 191 172 10 30
CITALOPRAM HBR 182 168 11 16
METOPROLOL TARTRATE 173 166 12 14
FUROSEMIDE 173 167 12 7
PRAVASTATIN SODIUM 171 142 14 21
SPIRONOLACTONE 163 158 15 47
ZOLPIDEM TARTRATE 153 142 16 20
OMEPRAZOLE 150 140 17 6
HYDROCHLOROTHIAZIDE 150 143 17 11
METOPROLOL SUCCINATE 144 135 19 17
METFORMIN HCL 132 131 20 9
CARVEDILOL 122 110 21 22
GABAPENTIN 116 116 22 13
FLUTICASONE PROPIONATE 112 109 23 32
ALLOPURINOL 108 106 24 27
TRIAMTERENE-HCTZ 107 106 25 46
TAMSULOSIN HCL 102 102 26 26
SERTRALINE HCL 100 95 27 23
POTASSIUM CHLORIDE 99 88 28 8
ATENOLOL 98 76 29 18
DIOVAN 97 97 30 56
ESCITALOPRAM OXALATE 94 90 31 54
NEXIUM 93 89 32 33
CIPROFLOXACIN HCL 89 85 33 55
AMITRIPTYLINE HCL 87 79 R 34 66
QUINAPRIL HCL 85 85 35 186
METHYLPREDNISOLONE 80 70 36 171
LEVOXYL 75 75 37 173
DONEPEZIL HCL 69 69 38 25
TRAMADOL HCL 61 61 39 19
LOSARTAN-HYDROCHLOROTHIAZIDE 61 59 39 44
AZITHROMYCIN 60 59 41 48
LIPITOR 60 53 41 109
METFORMIN HCL ER 59 59 43 74
TRAMADOL HCL-ACETAMINOPHEN 59 59 43 224
DOXYCYCLINE HYCLATE 58 57 45 78
ALENDRONATE SODIUM 55 51 46 24
AMOX TR-POTASSIUM CLAVULANATE 54 49 47 153
BUPROPION HCL SR 54 49 47 157
BENICAR 52 52 49 160
LANSOPRAZOLE 52 52 49 139
KLOR-CON M10 50 50 51 117
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 16, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.